# Radiopharm Theranostics Ltd: Form 20-F for the period ended Jun 30, 2026

- Company: [Radiopharm Theranostics Ltd](/companies/radx.md) (CIK 1949257)
- Form: 20-F
- Filed: 2026-09-30
- Accepted by EDGAR: Sep 30, 2026, 15:16 ET
- Period: 2026-06-30
- Accession: 0001213900-26-105181
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1949257/000121390026105181/ea0306842-20f_radiopharm.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1949257/000121390026105181/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2026-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Shares outstanding | at 2026-06-30 | 3,544,216,160 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1949257/000121390026105181/ea0306842-20f_radiopharm.htm

Filed Sep 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-105181. Last ingested by Listed: Nov 14, 2026, 23:08 ET. No prices; not investment advice.
